Your browser doesn't support javascript.
loading
Verification of Death by Neurologic Criteria: A Survey of 12 Organ Procurement Organizations Across the United States.
Sarhadi, Kasra; Hendershot, Kristopher A; Smith, Natalie; Souter, Michael; Creutzfeldt, Claire; Lele, Abhijit; Maciel, Carolina; Busl, Katharina; Balogh, Julius; Greer, David; Lewis, Ariane; Wahlster, Sarah.
Afiliação
  • Sarhadi K; University of Washington, Seattle, WA, USA. ksarhadi@uw.edu.
  • Hendershot KA; University of Washington, Seattle, WA, USA.
  • Smith N; University of Washington, Seattle, WA, USA.
  • Souter M; University of Washington, Seattle, WA, USA.
  • Creutzfeldt C; University of Washington, Seattle, WA, USA.
  • Lele A; University of Washington, Seattle, WA, USA.
  • Maciel C; University of Florida, Gainesville, FL, USA.
  • Busl K; University of Florida, Gainesville, FL, USA.
  • Balogh J; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Greer D; Boston University School of Medicine, Boston, MA, USA.
  • Lewis A; NYU Langone Medical Center, New York, NY, USA.
  • Wahlster S; University of Washington, Seattle, WA, USA.
Neurocrit Care ; 2024 May 15.
Article em En | MEDLINE | ID: mdl-38750393
ABSTRACT

BACKGROUND:

The Center for Medicare and Medicaid Services requires Organ Procurement Organizations (OPOs) to verify and document that any potential organ donor has been pronounced dead per applicable legal requirements of local, state, and federal laws. However, OPO practices regarding death by neurologic criteria (DNC) verification are not standardized, and little is known about their DNC verification processes. This study aimed to explore OPO practices regarding DNC verification in the United States.

METHODS:

An electronic survey was sent to all 57 OPOs in the United States from June to September 2023 to assess verification of policies and practices versus guidelines, concerns about policies and practices, processes to address concerns about DNC determination, and communication practices.

RESULTS:

Representatives from 12 OPOs across six US regions completed the entire survey; 8 of 12 reported serving > 50 referral hospitals. Most respondents (11 of 12) reported comparing their referral hospital's DNC policies with the 2010 American Academy of Neurology Practice Parameter and/or other (4 of 12) guidelines. Additionally, most (10 of 12) reported independently reviewing and verifying each DNC determination. Nearly half (5 of 12) reported concerns about guideline-discordant hospital policies, and only 3 of 12 thought all referral hospitals followed the 2010 American Academy of Neurology Practice Parameter in practice. Moreover, 9 of 12 reported concerns about clinician knowledge surrounding DNC determination, and most (10 of 12) reported having received referrals for patients whose DNC declaration was ultimately reversed. All reported experiences in which their OPO requested additional assessments (11 of 12 clinical evaluation, 10 of 12 ancillary testing, 9 of 12 apnea testing) because of concerns about DNC determination validity.

CONCLUSIONS:

Accurate DNC determination is important to maintain public trust. Nearly all OPO respondents reported a process to verify hospital DNC policies and practices with medical society guidelines. Many reported concerns about clinician knowledge surrounding DNC determination and guideline-discordant policies and practices. Educational and regulatory advocacy efforts are needed to facilitate systematic implementation of guideline-concordant practices across the country.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article